Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes
only mild symptoms in the majority of the cases, while immunologic complications such as …
only mild symptoms in the majority of the cases, while immunologic complications such as …
Immunomodulating therapies in acute myocarditis and recurrent/acute pericarditis
The field of inflammatory disease of the heart or “cardio-immunology” is rapidly evolving due
to the wider use of non-invasive diagnostic tools able to detect and monitor myocardial …
to the wider use of non-invasive diagnostic tools able to detect and monitor myocardial …
Recent advances in pericarditis
E Bizzi, C Picchi, G Mastrangelo, M Imazio… - European Journal of …, 2022 - Elsevier
Pericardial diseases are an heterogeneous group of entities, ranging from acute pericarditis
to asymptomatic pericardial effusions. New advances in understanding the processes …
to asymptomatic pericardial effusions. New advances in understanding the processes …
Targeting cytokine storm as the potential anti-viral therapy: Implications in regulating SARS-CoV-2 pathogenicity
S Maity, A Santra, AV Hebbani, S Pulakuntla… - Gene, 2023 - Elsevier
The latest global pandemic corona virus disease− 2019 (COVID-19) caused by the virus
SARS-CoV-2 is still a matter of worrying concern both for the scientific communities and …
SARS-CoV-2 is still a matter of worrying concern both for the scientific communities and …
The clinical role of anakinra in the armamentarium against familial Mediterranean fever
ABSTRACT Introduction Familial Mediterranean Fever (FMF) is the most common
autoinflammatory disease that has mainly been treated with colchicine since 1972. A …
autoinflammatory disease that has mainly been treated with colchicine since 1972. A …
Amyloidosis and glomerular diseases in familial Mediterranean fever
R Siligato, G Gembillo, V Calabrese, G Conti… - Medicina, 2021 - mdpi.com
Familial Mediterranean fever (FMF) is a genetic autoinflammatory disease with autosomal
recessive transmission, characterized by periodic fever attacks with self-limited serositis …
recessive transmission, characterized by periodic fever attacks with self-limited serositis …
Novel pharmacotherapies for recurrent pericarditis: current options in 2020
E Tombetti, A Mulè, S Tamanini, L Matteucci… - Current Cardiology …, 2020 - Springer
Recent advances have shown impressive results by anti-interleukin 1 (IL-1) agents in
refractory idiopathic recurrent pericarditis. Purpose of Review We critically discuss the …
refractory idiopathic recurrent pericarditis. Purpose of Review We critically discuss the …
Treat-to-target strategies for the management of familial Mediterranean Fever in children
L Ehlers, E Rolfes, M Lieber, D Müller, E Lainka… - Pediatric …, 2023 - Springer
Background The objective of this initiative was to develop a treat-to-target (T2T) approach for
the management of patients with Familial Mediterranean Fever (FMF), including the …
the management of patients with Familial Mediterranean Fever (FMF), including the …
Efficacy and safety of anti-interleukin-1 treatment in familial Mediterranean fever patients: a systematic review and meta-analysis
Objectives FMF is the most common hereditary monogenic fever syndrome marked by
recurrent attacks of fever and polyserositis. Colchicine is the current recommended first-line …
recurrent attacks of fever and polyserositis. Colchicine is the current recommended first-line …
The efficacy of a single-dose anakinra injection during disease attack in pediatric familial Mediterranean fever
The aim of this retrospective study is to evaluate the efficacy of a single-dose anakinra
during familial Mediterranean fever (FMF) attacks and its effect on the duration, severity, and …
during familial Mediterranean fever (FMF) attacks and its effect on the duration, severity, and …